title: [A CASE OF ANAPHYLAXIS IN THE PEDIATRIC PATIENT WITH MILK ALLERGY DUE TO TRACES OF MILK PROTEIN IN THE LACTOSE USED AS AN EXCIPIENT OF INAVIR INHALATION].
abstract: The patient was a 6-year-old female with milk allergy and persistent asthma. She experienced anaphylactic reactions just after the inhalation of Inavir (Laninamivir Octanoate Hydrate) to treat flu infection. A skin-prick test showed positive reactions for Inavir inhaler powder and lactose used as an excipient but negative for Laninamivir. Same results were obtained in a drug-stimulated basophil activation test. The lactose excipient in Inavir inhaler powder was supposed to contain milk proteins, which caused anaphylactic reactions. To test this possibility, we examined the contamination of allergic milk proteins in the lactose excipient and found the smear band by silver staining, which was identified as β-lactoglobulin (β-LG) by Western blotting using specific monoclonal antibody and patient's sera. The β-LG in Inavir was supposed to be glycosylated with lactose because the molecular weight was slightly higher than β-LG standard reference as seen in mobility. In fact, the incubation with lactose in vitro tended to increase molecular weight. Following these results, we herein report that the trace amounts of β-LG contaminated in the lactose excipient of Inavir could cause immediate allergic reactions. The risk that the lactose-containing dry powder inhalers cause allergic reactions for patients with cow's milk allergy need to be reminded. In particular, the use for flu patients should be paid careful attention because of increased airway hypersensitivity in those patients.
authors.affiliation: Morikawa Pediatrics & Allergy Clinic.
authors.forename: Miki
authors.initials: M
authors.lastname: Morikawa
authors.forename: Yoshitomi
authors.initials: Y
authors.lastname: Kanemitsu
authors.forename: Hiroki
authors.initials: H
authors.lastname: Tsukamoto
authors.forename: Akimasa
authors.initials: A
authors.lastname: Morikawa
authors.forename: Yoshihisa
authors.initials: Y
authors.lastname: Tomioka
mesh_terms: D000707:Anaphylaxis / Q000209:etiology*; D002648:Child; D005260:Female; D006801:Humans; D007782:Lactoglobulins / Q000009:adverse effects* / Q000276:immunology; D007785:Lactose / Q000009:adverse effects* / Q000276:immunology; D016269:Milk Hypersensitivity / Q000276:immunology*; D009330:Nebulizers and Vaporizers
chemical_list: D007782:Lactoglobulins; D007785:Lactose